Last reviewed · How we verify

NCT04029779: PRF

Evaluation of Immediately Placed Dental Implants With Local Application of Injectable PRF in Periodontally Compromised Sites

Completed Phase 2 Last updated 12 December 2019
What this trial tests

Phase 2 trial testing I-PRF in Bone Density in 10 participants. Completed in 30 November 2019.

Timeline
11 November 2017
Primary endpoint
30 November 2019
30 November 2019

Quick facts

Lead sponsorKrishnadevaraya College of Dental Sciences & Hospital
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment10
Start date11 November 2017
Primary completion30 November 2019
Estimated completion30 November 2019
Sites1 location across India

Drugs / interventions tested

Conditions studied

Sponsor

Krishnadevaraya College of Dental Sciences & Hospital

Who can join

Adults 18 to 55, any sex, with Bone Density or Bone Loss, Alveolar. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present study is a human, prospective, parallel, randomised controlled clinical trial conducted to explore the efficacy of injectable PRF around dental implants. The trial is in accordance with the Consolidated Standards of Reporting Trials (CONSORT) criteria, 2010.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of I-PRF

Trials testing the same drug.

Other recruiting trials for Bone Density

Currently open trials in the same condition.

Other Krishnadevaraya College of Dental Sciences & Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04029779.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing